Control of Dopamine Signal in High-Order Receptor Complex on Striatal Astrocytes

Overview

Journal Int J Mol Sci

Publisher MDPI

Specialties Biochemistry
Chemistry
Molecular Biology

Date 2024 Aug 29

PMID 39201299

Authors

Sarah Amato

Monica Averna

Elisa Farsetti

Diego Guidolin

Marco Pedrazzi

Elena Gatta

Simona Candiani

Guido Maura

Luigi Francesco Agnati

Chiara Cervetto

Manuela Marcoli

Affiliations

Soon will be listed here.

Abstract

The receptor-receptor interaction (RRI) of G protein-coupled receptors (GPCRs) leads to new functional entities that are conceptually distinct from the simple addition of signals mediated by the activation of the receptors that form the heteromers. Focusing on astrocytes, there is evidence for the existence of inhibitory and facilitatory RRIs, including the heteromers formed by the adenosine A2A and the dopamine D2 receptors, by A2A and the oxytocin receptor (OTR), and the D2-OTR heteromers. The possible involvement of these receptors in mosaicism has never been investigated in striatal astrocytes. By biophysical and functional approaches, we focused our attention on the existence of an A2A-D2-OTR high-order receptor complex and its role in modulating cytosolic calcium levels and endogenous glutamate release, when striatal astrocyte processes were stimulated with 4-aminopyridine. Functional data indicate a permissive role of OTR on dopamine signaling in the regulation of the glutamatergic transmission, and an inhibitory control mediated by A2A on both the D2-mediated signaling and on the OTR-facilitating effect on D2. Imaging biochemical and bioinformatic evidence confirmed the existence of the A2A-D2-OTR complex and its ternary structure in the membrane. In conclusion, the D2 receptor appears to be a hotspot in the control of the glutamate release from the astrocytic processes and may contribute to the regulation and integration of different neurotransmitter-mediated signaling in the striatum by the A2A-D2-OTR heterotrimers. Considering the possible selectivity of allosteric interventions on GPCRs organized as receptor mosaics, A2A-D2-OTR heterotrimers may offer selective pharmacological targets in neuropsychiatric disorders and neurodegenerative diseases.

References

Cervetto C, Venturini A, Guidolin D, Maura G, Passalacqua M, Tacchetti C . Homocysteine and A2A-D2 Receptor-Receptor Interaction at Striatal Astrocyte Processes. J Mol Neurosci. 2018; 65(4):456-466. DOI: 10.1007/s12031-018-1120-4. View

Lee J, Patel D, Stahle J, Park S, Kern N, Kim S . CHARMM-GUI Membrane Builder for Complex Biological Membrane Simulations with Glycolipids and Lipoglycans. J Chem Theory Comput. 2018; 15(1):775-786. DOI: 10.1021/acs.jctc.8b01066. View

Erbas O, Oltulu F, Taskiran D . Suppression of exaggerated neuronal oscillations by oxytocin in a rat model of Parkinson's disease. Gen Physiol Biophys. 2013; 32(4):517-25. DOI: 10.4149/gpb_2013055. View

Kruyer A, Kalivas P . Astrocytes as cellular mediators of cue reactivity in addiction. Curr Opin Pharmacol. 2020; 56:1-6. PMC: 7910316. DOI: 10.1016/j.coph.2020.07.009. View

Popoli P, Pezzola A, Torvinen M, Reggio R, Pintor A, Scarchilli L . The selective mGlu(5) receptor agonist CHPG inhibits quinpirole-induced turning in 6-hydroxydopamine-lesioned rats and modulates the binding characteristics of dopamine D(2) receptors in the rat striatum: interactions with adenosine A(2a) receptors. Neuropsychopharmacology. 2001; 25(4):505-13. DOI: 10.1016/S0893-133X(01)00256-1. View

Krieger E, Joo K, Lee J, Lee J, Raman S, Thompson J . Improving physical realism, stereochemistry, and side-chain accuracy in homology modeling: Four approaches that performed well in CASP8. Proteins. 2009; 77 Suppl 9:114-22. PMC: 2922016. DOI: 10.1002/prot.22570. View

Cervetto C, Mazzotta M, Frattaroli D, Alloisio S, Nobile M, Maura G . Calmidazolium selectively inhibits exocytotic glutamate release evoked by P2X7 receptor activation. Neurochem Int. 2012; 60(8):768-72. DOI: 10.1016/j.neuint.2012.02.034. View

Matott M, Kline D, Hasser E . Glial EAAT2 regulation of extracellular nTS glutamate critically controls neuronal activity and cardiorespiratory reflexes. J Physiol. 2017; 595(17):6045-6063. PMC: 5577520. DOI: 10.1113/JP274620. View

Rashid A, So C, Kong M, Furtak T, El-Ghundi M, Cheng R . D1-D2 dopamine receptor heterooligomers with unique pharmacology are coupled to rapid activation of Gq/11 in the striatum. Proc Natl Acad Sci U S A. 2006; 104(2):654-9. PMC: 1766439. DOI: 10.1073/pnas.0604049104. View

10.

Neely M, Schmidt D, Deutch A . Cortical regulation of dopamine depletion-induced dendritic spine loss in striatal medium spiny neurons. Neuroscience. 2007; 149(2):457-64. PMC: 2094700. DOI: 10.1016/j.neuroscience.2007.06.044. View

11.

Borroto-Escuela D, Narvaez M, Wydra K, Pintsuk J, Pinton L, Jimenez-Beristain A . Cocaine self-administration specifically increases A2AR-D2R and D2R-sigma1R heteroreceptor complexes in the rat nucleus accumbens shell. Relevance for cocaine use disorder. Pharmacol Biochem Behav. 2017; 155:24-31. DOI: 10.1016/j.pbb.2017.03.003. View

12.

Kim K, Kim J, Park J, Suh Y, Jou I, Joe E . DJ-1 associates with lipid rafts by palmitoylation and regulates lipid rafts-dependent endocytosis in astrocytes. Hum Mol Genet. 2013; 22(23):4805-17. DOI: 10.1093/hmg/ddt332. View

13.

Shao W, Zhang S, Tang M, Zhang X, Zhou Z, Yin Y . Suppression of neuroinflammation by astrocytic dopamine D2 receptors via αB-crystallin. Nature. 2012; 494(7435):90-4. DOI: 10.1038/nature11748. View

14.

Guidolin D, Marcoli M, Tortorella C, Maura G, Agnati L . Receptor-Receptor Interactions as a Widespread Phenomenon: Novel Targets for Drug Development?. Front Endocrinol (Lausanne). 2019; 10:53. PMC: 6387912. DOI: 10.3389/fendo.2019.00053. View

15.

Mariotti L, Losi G, Lia A, Melone M, Chiavegato A, Gomez-Gonzalo M . Interneuron-specific signaling evokes distinctive somatostatin-mediated responses in adult cortical astrocytes. Nat Commun. 2018; 9(1):82. PMC: 5758790. DOI: 10.1038/s41467-017-02642-6. View

16.

Amato S, Averna M, Guidolin D, Ceccoli C, Gatta E, Candiani S . Heteromerization of Dopamine D2 and Oxytocin Receptor in Adult Striatal Astrocytes. Int J Mol Sci. 2023; 24(5). PMC: 10002782. DOI: 10.3390/ijms24054677. View

17.

Soderstrom K, OMalley J, Levine N, Sortwell C, Collier T, Steece-Collier K . Impact of dendritic spine preservation in medium spiny neurons on dopamine graft efficacy and the expression of dyskinesias in parkinsonian rats. Eur J Neurosci. 2010; 31(3):478-90. PMC: 2940228. DOI: 10.1111/j.1460-9568.2010.07077.x. View

18.

Neumann M, Muller V, Gorner K, Kretzschmar H, Haass C, Kahle P . Pathological properties of the Parkinson's disease-associated protein DJ-1 in alpha-synucleinopathies and tauopathies: relevance for multiple system atrophy and Pick's disease. Acta Neuropathol. 2004; 107(6):489-96. DOI: 10.1007/s00401-004-0834-2. View

19.

Fahn S, Oakes D, Shoulson I, Kieburtz K, Rudolph A, Lang A . Levodopa and the progression of Parkinson's disease. N Engl J Med. 2004; 351(24):2498-508. DOI: 10.1056/NEJMoa033447. View

20.

Anderson C, Swanson R . Astrocyte glutamate transport: review of properties, regulation, and physiological functions. Glia. 2000; 32(1):1-14. View